# Ixazomib Citrate Capsules 3mg (ニンラーロカプセル３ｍｇ)

> Prescription product approved in Japan and listed on the NHI drug price list (YJ code 4291049M2020). Nifuji Pharma sources it for licensed healthcare providers, institutions, and distributors; availability, documentation, and export eligibility are confirmed on inquiry.

- **YJ code:** 4291049M2020
- **Product name (Japanese):** ニンラーロカプセル３ｍｇ
- **English title:** Ixazomib Citrate Capsules 3mg
- **Active ingredient:** イキサゾミブクエン酸エステル
- **Active ingredient (INN):** Ixazomib Citrate
- **Strength / unit:** ３ｍｇ１カプセル
- **Route:** Oral (内用薬)
- **Therapeutic category:** 42 Antineoplastics (腫瘍用薬) › 429 Other antineoplastics (その他の腫瘍用薬)
- **Manufacturer:** Takeda Pharmaceutical (武田薬品工業)
- **NHI price (reference only):** JPY 125640 per ３ｍｇ１カプセル
- **Regulatory status:** Approved in Japan; listed on the NHI drug price list
- **Web page:** https://www.nifujipharma.com/drugs/4291049M2020
- **JSON:** https://www.nifujipharma.com/api/drugs/4291049M2020

## How to request a quotation

Submit the contact form with the product name, quantity, and destination country: https://www.nifujipharma.com/?product=Ixazomib%20Citrate%20Capsules%203mg%20(%E3%83%8B%E3%83%B3%E3%83%A9%E3%83%BC%E3%83%AD%E3%82%AB%E3%83%97%E3%82%BB%E3%83%AB%EF%BC%93%EF%BD%8D%EF%BD%87)%20%2F%20YJ%204291049M2020#contact

Quotes are for qualified business customers only (licensed healthcare providers, medical institutions, distributors). Payment is by bank transfer in Japanese Yen. Product collection typically takes 2-4 weeks after order confirmation, followed by export procedures and shipping.

## Other listed products with Ixazomib Citrate

- [Ixazomib Citrate Capsules 2.3mg (ニンラーロカプセル２．３ｍｇ)](https://www.nifujipharma.com/drugs/4291049M1024) — ２．３ｍｇ１カプセル, Takeda Pharmaceutical
- [Ixazomib Citrate Capsules 4mg (ニンラーロカプセル４ｍｇ)](https://www.nifujipharma.com/drugs/4291049M3027) — ４ｍｇ１カプセル, Takeda Pharmaceutical
- [Ixazomib Citrate Capsules 0.5mg (ニンラーロカプセル０．５ｍｇ)](https://www.nifujipharma.com/drugs/4291049M4023) — ０．５ｍｇ１カプセル, Takeda Pharmaceutical